ORTIN LABORATORIES Share Price

₹ 13.88

+₹0.53 (3.97%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: ORTINGLOBE

ORTIN LABORATORIES Share Price Today

As of 3 Nov 2026, ORTIN LABORATORIES share price is ₹13.88. The stock opened at ₹13.35, compared to its previous close of ₹13.35. During today's trading session, ORTIN LABORATORIES share price moved in the range of ₹12.60 to ₹13.88, with an average price of ₹13.24 for the day. Looking at its last 52-week, the stock has touched a low of ₹10.83 and a high of ₹21.30. On the performance front, ORTIN LABORATORIES share price has declined by 12.19% over the last six months and is up 20.98% on a year-on-year basis.

₹12.60

3.97% up today

₹13.88

1D LOW

1D HIGH

ORTIN LABORATORIES Stock Insights

Latest Earning

Op Profit TrendUp by 130.28% QoQ

Latest Earning

Net Profit TrendUp by 122.92% QoQ

Latest Earning

Revenue TrendDown by 20.04% QoQ

Stock Performance

OutperformingBeat Nifty by 27.63 % in last 1 year

Shareholding Pattern

PromoterPromoter increased stake by 0.23%

Shareholding Pattern

FIIFII decreased stake by 62.83%

ORTIN LABORATORIES Stock Insights

Latest Earning

Op Profit TrendUp by 130.28% QoQ

Latest Earning

Net Profit TrendUp by 122.92% QoQ

Latest Earning

Revenue TrendDown by 20.04% QoQ

Stock Performance

OutperformingBeat Nifty by 27.63 % in last 1 year

Shareholding Pattern

PromoterPromoter increased stake by 0.23%

Shareholding Pattern

FIIFII decreased stake by 62.83%

ORTIN LABORATORIES stock performance
Open	₹13.35
High	₹13.88
Low	₹12.60
Prev. close	₹13.35

ORTIN LABORATORIES trading activity
Volume	1,617
Average traded price	₹12.82
Last traded time	03:29:27 02 Nov
Last traded quantity	9

₹12.25₹14.97

Circuit Low

Circuit High

₹10.83₹21.30

52-Week Low

52-Week High

Circuit

₹12.25

₹14.97

52-week

₹10.83

₹21.30

Mkt Cap Cr

10.86

P/E

-12.03

P/B

8.77

ROA

-19.35%

ROE

-59.85%

ROCE

-32.17%

Quick Ratio

1.6

EV/EBITDA

-12.65

Mkt Cap Cr

10.86

P/E

-12.03

P/B

8.77

ROA

-19.35%

ROE

-59.85%

ROCE

-32.17%

Quick Ratio

1.6

EV/EBITDA

-12.65

Based on fundamentals, this stock's

Performance

Very Poor

Ortin Global has not beaten FD return of 7%

Valuation

Overvalued

Ortin Global appears overvalued compared to its peers

Earnings

Neutral

Ortin Global earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ORTIN LABORATORIES Company Background

ISIN

INE749B01020

Sector Market Cap

₹ 10.86 Cr

Ortin Global Limited is an India-based company, which is engaged in the manufacturing and trading of pharmaceuticals, drugs and intermediates, to manufacture, sell or export all types of medicines, including ayurvedic, homeopathic, Unani, biochemical, nature cure and others. The Company is also engaged in the real estate business.

ORTIN LABORATORIES Financial Highlights

Revenue: ORTIN LABORATORIES reported revenue of ₹0.42 crore in FY26 vs ₹0.38 crore in FY25. It showed an increase of 10.53% on a yearly basis.
Operating Profit: ORTIN LABORATORIES reported an operating loss of ₹0.72 crore in FY26 vs ₹0.84 crore in FY25. It showed an increase of 14.29% on a year-on-year basis.
Net Profit: ORTIN LABORATORIES reported a net loss of ₹0.74 crore in FY26 vs ₹0.85 crore in FY25. It showed an increase of 12.94% on a yearly basis.

ORTIN LABORATORIES Quarterly Result Highlights

ORTIN LABORATORIES reported revenue of ₹15.96 crore in Jun 2012, compared with ₹19.96 crore in Mar 2012, representing a decrease of 20.04% on a quarter-on-quarter (QoQ) basis.
ORTIN LABORATORIES reported an operating profit of ₹0.66 crore in Jun 2012, compared with ₹2.18 crore in Mar 2012, representing an increase of 130.28% on a quarter-on-quarter (QoQ) basis.
ORTIN LABORATORIES reported a profit of ₹0.44 crore in Jun 2012, compared with ₹1.92 crore in Mar 2012, reflecting an increase of 122.92% on a QoQ basis.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

1.24%

FII

0.67%

Other DII

0.00%

Retail and other

98.09%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	1.68%
Mar 2026	1.68%
Jun 2026	1.80%
Sep 2026	0.67%

ORTIN LABORATORIES Investment Returns

1 day

+1.95%

1 week

+3.42%

1 month

-6.27%

1 year

+20.98%

3 years

-23.75%

5 years

-56.45%

ORTIN LABORATORIES Share Price History

ORTIN LABORATORIES share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹13.35 / ₹13.61	+1.95%
30 Oct 26	₹13.50 / ₹13.35	+1.68%
29 Oct 26	₹12.41 / ₹13.13	+5.80%
28 Oct 26	₹12.50 / ₹12.41	-2.67%
27 Oct 26	₹12.51 / ₹12.75	-3.12%
26 Oct 26	₹14.00 / ₹13.16	+2.49%
23 Oct 26	₹13.60 / ₹12.84	-3.60%
22 Oct 26	₹13.56 / ₹13.32	-1.55%
21 Oct 26	₹14.56 / ₹13.53	-6.17%
19 Oct 26	₹14.35 / ₹14.42	+0.56%

ORTIN LABORATORIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2012
Revenue	86.05
Operating profit	2.61
Net profit	1.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹0.10	₹0.34	₹2.11	₹6.02
Other Income	₹0.31	₹0.04	₹0.17	₹0.04
Total Revenue	₹0.42	₹0.38	₹2.28	₹6.06
Total Expenses	₹1.14	₹1.24	₹9.36	₹6.15
Profit Before Tax	-₹0.72	-₹0.84	-₹7.08	-₹0.11
Tax	₹0.02	₹0.01	₹0.97	-₹0.02
Profit After Tax	-₹0.74	-₹0.85	-₹8.04	-₹0.09
EPS - Basic	-₹0.91	-₹1.04	-₹9.89	-₹0.12
EPS - Diluted	-₹0.91	-₹1.04	-₹9.89	-₹0.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	-₹0.72	-₹0.84	-₹7.08	-₹0.11
Income before WC changes	-₹0.76	-₹0.82	-₹4.22	₹0.53
Change in Assets	-₹0.65	₹0.90	₹2.32	-₹1.08
Change in Liabilities	₹0.85	-₹0.48	-₹1.59	₹0.30
Change in WC	₹0.20	₹0.41	₹0.72	-₹0.78
Cash flow from Operations	-₹0.56	-₹0.41	-₹4.79	-₹0.25
Cash flow from Investing	₹0.04	₹0.00	₹12.00	₹0.01
Cash flow from Financing	₹0.75	₹0.33	-₹3.49	₹0.90
Total Cash Flow	₹0.23	-₹0.09	₹3.72	₹0.66
Cash (Start of the year)	₹0.37	₹0.46	-₹3.26	-₹3.92
Cash (End of the year)	₹0.61	₹0.37	₹0.46	-₹3.26

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹0.81	₹0.44	₹0.32	₹14.66
Current Assets	₹3.84	₹3.34	₹6.34	₹6.54
Total Assets	₹4.65	₹3.78	₹6.66	₹21.20
Current Liabilities	₹2.41	₹1.55	₹2.04	₹6.98
Net Current Asset	₹1.43	₹1.79	₹4.31	-₹0.44
Non-Current Liabilities	₹1.01	₹0.25	₹1.80	₹3.35
Equity Capital	₹1.24	₹1.98	₹2.82	₹10.86
Total Equity & Liabilities	₹4.65	₹3.78	₹6.66	₹21.20